Our study demonstrated that COPD was independently associated with a lower prevalence of EGFR mutations among NSCLC patients, after taking age, gender, smoking, and histology into account, and the number of subjects enrolled was larger. This evidence concerns the gene EGFR and chronic obstructive pulmonary disease.